Appendix Carcinoma — Trials

Appendix Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

35 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 14
Recruiting: 9
Ph III recruiting: 1
Growth YoY: —
Industry share: 7%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07283939	Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays	recruiting	N/A	420	Alliance for Clinical Trials in OncologyOTHER	3	Sep 2, 2026	clinicaltrials
NCT05947838	A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma	recruiting	N/A	48	M.D. Anderson Cancer CenterOTHER	1	May 18, 2026	clinicaltrials